EOM Pharmaceutical Holdings Inc. (IMUC)

[bob smith]

requirements:

should read these 2 articles prior to be reading the next link.

http://thestockmarketwatch.com/newsletters/2011/02/27/timelesswealth-net-imuc-to-uplist-to-amex/

http://seekingalpha.com/article/279639-uplisting-may-be-next-for-immunocellular-therapeutics

below:


http://www.amex.com/equities/howToLst/Eq_HTL_ListStandards.html
or

http://www.mondaq.com/unitedstates/x/155562/Mergers+Acquisitions/SEC+Approves+More+Rigorous+Listing+Requirements+Of+The+Major+US+Stock+Exchanges+For+Reverse+Merger+Companies

2. maintained a closing stock price of $4 (or, in the case of the NYSE Amex, either $3 or $2, depending on the applicable listing standard) per share or higher for a sustained period of time, but in no event for less than 30 of the most recent 60 trading days prior to the filing of the initial listing application and prior to listing; and


3. timely filed all required periodic financial reports with the SEC or other regulatory authority (e.g., Forms 10-Q, 10-K or 20-F), including at least one annual report containing audited financial statements for a full fiscal year commencing after filing the information described above.

gl